Synthesis, Pharmacological Evaluation, and σ1Receptor Interaction Analysis of Hydroxyethyl Substituted Piperazines

Journal of Medicinal Chemistry
2014.0

Abstract

Starting from (S)- or (R)-aspartate, three synthetic strategies were explored to prepare hydroxyethyl substituted piperazines with different substituents at the N-atoms. σ receptor affinity was recorded using receptor material from both animal and human origin. σ1 affinities determined with guinea pig brain and human RPMI 8226 tumor cell lines differed slightly but showed the same tendency. (S)-2-[4-(Cyclohexylmethyl)-1-(naphthalene-2-ylmethyl)piperazin-2-yl]ethanol (7c) revealed the highest affinity at human σ1 receptors (Ki = 6.8 nM). The potent σ1 receptor ligand 7c was able to inhibit selectively the growth of three human tumor cell lines with IC50 values in the low micromolar range. The reduced growth of the RPMI-8226 cell line was caused by apoptosis. The interaction of 7c with the σ1 receptor was analyzed in detail using the 3D homology model of the σ1 receptor. The calculated free binding energies of all hydroxyethylpiperazines nicely correlate with their recorded affinities toward the human σ1 receptor.

Knowledge Graph

Similar Paper

Synthesis, Pharmacological Evaluation, and σ<sub>1</sub>Receptor Interaction Analysis of Hydroxyethyl Substituted Piperazines
Journal of Medicinal Chemistry 2014.0
Rigidity versus Flexibility: Is This an Issue in σ<sub>1</sub>Receptor Ligand Affinity and Activity?
Journal of Medicinal Chemistry 2016.0
Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their σ receptor affinity and cytotoxic activity
Bioorganic &amp; Medicinal Chemistry 2009.0
Synthesis and binding assays of novel 3,3-dimethylpiperidine derivatives with various lipophilicities as σ1 receptor ligands
Bioorganic &amp; Medicinal Chemistry 2011.0
Synthesis of bridged piperazines with σ receptor affinity
European Journal of Medicinal Chemistry 2007.0
Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands
European Journal of Medicinal Chemistry 2013.0
Exploring the Importance of Piperazine N-Atoms for σ<sub>2</sub>Receptor Affinity and Activity in a Series of Analogs of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28)
Journal of Medicinal Chemistry 2009.0
Novel σ1 antagonists designed for tumor therapy: Structure – activity relationships of aminoethyl substituted cyclohexanes
European Journal of Medicinal Chemistry 2021.0
Synthesis of Bicyclic σ Receptor Ligands with Cytotoxic Activity
Journal of Medicinal Chemistry 2007.0
4-(Tetralin-1-yl)- and 4-(Naphthalen-1-yl)alkyl Derivatives of 1-Cyclohexylpiperazine as σ Receptor Ligands with Agonist σ<sub>2</sub> Activity
Journal of Medicinal Chemistry 2004.0